Bristol-Myers Squibb Company (BMY) Option Bulls Buoyed By Deal-Making

Bristol-Myers Squibb Co (BMY) will sell the rights to its cancer drug to Eli Lilly and Co (LLY)

Apr 16, 2015 at 2:24 PM
facebook twitter linkedin


Option traders have been initiating long calls over puts at a rapid-fire rate on Bristol-Myers Squibb Co (NYSE:BMY) in recent months. In fact, at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), BMY's 50-day call/put volume ratio of 5.03 ranks 1 percentage point from a 52-week peak.

Echoing this call-skewed bias is the security's Schaeffer's put/call open interest ratio (SOIR) of 0.41, which rests lower than 85% of all similar readings taken in the past year. Simply stated, short-term speculators have been more call-heavy toward BMY just 15% of the time during the last 12 months.

In today's session, calls are trading at 1.2 times what's typically seen at this point in the day, and are outpacing puts by an 8-to-1 ratio. Per the equity's 30-day at-the-money implied volatility -- which is up 3.8% at 24.4% -- short-term contracts are seeing increased attention. Drilling down, the ISE has confirmed buy-to-open activity at BMY's weekly 4/24 64-strike call, meaning speculators are betting on a breakout above $64 by next Friday's close, when the series expires.

On the charts, Bristol-Myers Squibb Co (NYSE:BMY) has been put in a strong performance over the past year, up 28.8% to trade at $63.72. Off the charts, the biopharmaceutical firm has been making a string of deals of late, including today's announcement that it will shift full North American commercialization rights (subscription required) of its cancer drug, Erbitux, to Eli Lilly and Co (NYSE:LLY).

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners